Literature DB >> 32577113

Automated Mobile Phone Messaging Utilizing a Cognitive Behavioral Intervention: A Pilot Investigation.

Edward O Rojas1, Chris A Anthony1, Jill Kain1, Natalie Glass1, Apurva S Shah2, Tammy Smith1, Benjamin J Miller1.   

Abstract

Background: In the setting of outpatient orthopaedic surgery, this pilot study utilized automated mobile messaging to assess (1) the feasibility of and interaction rates with a software delivered cognitive behavior therapy (CBT) intervention for postoperative opioid utilization, (2) the reliability of patient reported opioid utilization through our platform, (3) daily patient reported pain and opioid utilization within the first two postoperative weeks, and (4) the effect of software delivered CBT intervention on patient reported opioid utilization.
Methods: Musculoskeletal tumor patients scheduled for outpatient surgery were randomized into two study groups. Control patients received standard postoperative communication limited to a two-week postoperative follow-up visit. The intervention group received automated daily text-messages regarding pain, opioid utilization, and a daily CBT intervention. Interventional group patients also completed a patient satisfaction questionnaire at their two-week follow-up. Completion rates of all software delivered questions were determined in the interventional group. Median values of opioid utilization and interquartile range (IQR) were determined to compare utilization between groups. Spearman correlation coefficients were used to determine reliability of patient reported opioid utilization in the interventional group.
Results: Fourteen patients completed the pilot study (seven controls, seven intervention). Patients in the intervention arm completed 90% of pain and opioid questions. Intervention group patients utilized less of their daily prescribed opioid medication (20%, IQR:10%-27%) compared to controls (50%, IQR:4%-68%). Correlation between in-office pill counts and patient reported opioid medication utilization via our software messaging system was high (r=0.90, p=0.037).
Conclusion: Automated mobile phone messaging in outpatient tumor surgery yielded high interaction rates. Patient reported opioid utilization obtained through our platform demonstrated a high correlation with in-office pill counts. CBT delivered via automated mobile phone messaging demonstrated decreased opioid utilization in this pilot investigation.Level of evidence: II.
Copyright © The Iowa Orthopaedic Journal 2019.

Entities:  

Keywords:  cognitive behavior therapy (cbt); mhealth; musculoskeletal tumors; opioids; pain management

Year:  2019        PMID: 32577113      PMCID: PMC7047297     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  26 in total

1.  Utilization of a text-messaging robot to assess intraday variation in concussion symptom severity scores.

Authors:  Christopher A Anthony; Andrew R Peterson
Journal:  Clin J Sport Med       Date:  2015-03       Impact factor: 3.638

2.  Use of an Automated Mobile Phone Messaging Robot in Postoperative Patient Monitoring.

Authors:  Chris A Anthony; Ericka A Lawler; Christina M Ward; Ines C Lin; Apurva S Shah
Journal:  Telemed J E Health       Date:  2017-06-16       Impact factor: 3.536

3.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

4.  The opioid epidemic: impact on orthopaedic surgery.

Authors:  Brent J Morris; Hassan R Mir
Journal:  J Am Acad Orthop Surg       Date:  2015-05       Impact factor: 3.020

Review 5.  Inadequate pain relief and consequences in oncological elderly patients.

Authors:  Carlo Caltagirone; Ilaria Spoletini; Walter Gianni; Gianfranco Spalletta
Journal:  Surg Oncol       Date:  2009-12-16       Impact factor: 3.279

6.  Relationships between patient knowledge and the severity of side effects, daily nutrient intake, psychological status, and performance status in lung cancer patients.

Authors:  J Tian; L N Jia; Z C Cheng
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

7.  Text Messaging (SMS) Helping Cancer Care in Patients Undergoing Chemotherapy Treatment: a Pilot Study.

Authors:  Timóteo Matthies Rico; Karina Dos Santos Machado; Vanessa Pellegrini Fernandes; Samanta Winck Madruga; Patrícia Tuerlinckx Noguez; Camila Rose Guadalupe Barcelos; Mateus Madail Santin; Cristiane Rios Petrarca; Samuel Carvalho Dumith
Journal:  J Med Syst       Date:  2017-10-09       Impact factor: 4.460

8.  Opioid Consumption After Rotator Cuff Repair.

Authors:  Robert W Westermann; Chris A Anthony; Nic Bedard; Natalie Glass; Matt Bollier; Carolyn M Hettrich; Brian R Wolf
Journal:  Arthroscopy       Date:  2017-05-29       Impact factor: 4.772

Review 9.  Psychological treatments for the management of postsurgical pain: a systematic review of randomized controlled trials.

Authors:  Judith L Nicholls; Muhammad A Azam; Lindsay C Burns; Marina Englesakis; Ainsley M Sutherland; Aliza Z Weinrib; Joel Katz; Hance Clarke
Journal:  Patient Relat Outcome Meas       Date:  2018-01-19

Review 10.  Assessing the Efficacy of Mobile Health Apps Using the Basic Principles of Cognitive Behavioral Therapy: Systematic Review.

Authors:  Amy Leigh Rathbone; Laura Clarry; Julie Prescott
Journal:  J Med Internet Res       Date:  2017-11-28       Impact factor: 5.428

View more
  2 in total

Review 1.  The Use of mHealth in Orthopedic Surgery: A Scoping Review.

Authors:  Sara Dionisi; Noemi Giannetta; Emanuele Di Simone; Francesco Ricciardi; Gloria Liquori; Aurora De Leo; Lorenzo Moretti; Christian Napoli; Marco Di Muzio; Giovanni Battista Orsi
Journal:  Int J Environ Res Public Health       Date:  2021-11-28       Impact factor: 3.390

2.  Postoperative Cognitive Behavioral Intervention in Patients with Coronary Heart Disease Based on the Effect of Nursing Process Reengineering.

Authors:  Ying Xiong; Yan Liu; Jianying Cui
Journal:  Biomed Res Int       Date:  2022-09-17       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.